Corbus Pharmaceuticals Holdings (CRBP) Net Margin (2015 - 2021)

Corbus Pharmaceuticals Holdings' Net Margin history runs 7 years deep, the most recent figure standing at 14257.07% for Q3 2021.

• In Q3 2021, Net Margin fell 1149635.0% year-over-year to 14257.07%; the TTM figure through Jun 2022 stood at 45961.32% (down 4363525.0% YoY), while the FY2021 annual figure was 6350.09%, down 389388.0% from the prior year.
• Net Margin was 14257.07% for Q3 2021 at Corbus Pharmaceuticals Holdings, down from 12230.01% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 94.64% in Q4 2019 to a low of 14257.07% in Q3 2021.
• Historically, Net Margin has averaged 3679.42% across 5 years, with a median of 1404.73% in 2018.
• The sharpest annual moves came in 2019 and 2020: Net Margin surged 872462 bps in 2019, then sank 1332208 bps in 2020.
• A 5-year view of Net Margin shows it stood at 868.18% in 2017, then sank by 894 bps to 8629.98% in 2018, then soared by 101 bps to 94.64% in 2019, then plunged by 1378 bps to 1209.33% in 2020, then sank by 1079 bps to 14257.07% in 2021.
• The last three Net Margin figures came in at 14257.07% (Q3 2021), 12230.01% (Q2 2021), and 2379.38% (Q1 2021), per Business Quant data.